Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathoge

mBio

Volumn 5, Issue 3, 2014, Pages

  Doolittle, J M ^a   Webster Cyriaque, J ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; TRANSCRIPTION FACTOR RUNX3; UVOMORULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; CANCER GROWTH; CANCER RISK; CPG ISLAND; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; DNA METHYLATION; DNA TUMOR VIRUS; EPIGENETICS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HELICOBACTER PYLORI; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; MICROFLORA; MIXED INFECTION; NONHUMAN; ORGANISMAL INTERACTION; OXIDATIVE STRESS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; UTERINE CERVIX CANCER; VAGINITIS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; GENETIC EPIGENESIS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MICROBIOLOGY; VIROLOGY; VIRUS ACTIVATION;

BACTERIAL INFECTIONS; COINFECTION; DNA TUMOR VIRUSES; EPIGENESIS, GENETIC; HOST-PATHOGEN INTERACTIONS; HUMANS; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 84903973616     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01015-14     Document Type: Review

References (97)

1. Portela A, Esteller M. 2010. Epigenetic modifications and human disease. Nat. Biotechnol. 28: 1057-1068. http://dx. doi. org/10. 1038/nbt. 1685.
2. Dong X, Greven MC, Kundaje A, Djebali S, Brown JB, Cheng C, Gingeras TR, Gerstein M, Guigó R, Birney E, Weng Z. 2012. Modeling gene expression using chromatin features in various cellular contexts. Genome Biol. 13: R53. http://dx. doi. org/10. 1186/gb-2012-13-9-r53.
3. Knipe DM, Lieberman PM, Jung JU, McBride AA, Morris KV, Ott M, Margolis D, Nieto A, Nevels M, Parks RJ, Kristie TM. 2013. Snapshots: chromatin control of viral infection. Virology 435: 141-156. http://dx. doi. org/10. 1016/j. virol. 2012. 09. 023.
4. Pantry SN, Medveczky PG. 2009. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin. Cancer Biol. 19: 153-157. http://dx. doi. org/10. 1016/j. semcancer. 2009. 02. 010.
5. Chen HS, Lu F, Lieberman PM. 2013. Epigenetic regulation of EBV and KSHV latency. Curr. Opin. Virol. 3:-251-259. http://dx. doi. org/10. 1016/j. coviro. 2013. 03. 004.
6. Woellmer A, Hammerschmidt W. 2013. Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation. Curr. Opin. Virol. 3: 260-265. http://dx. doi. org/10. 1016/j. coviro. 2013. 03. 005.
7. Mbonye U, Karn J. 2011. Control of HIV latency by epigenetic and non-epigenetic mechanisms. Curr. HIV Res. 9: 554-567. http://dx. doi. org/10. 2174/157016211798998736.
8. Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E. 2013. Reactivation of latent HIV by histone deacetylase inhibitors. Trends Microbiol. 21: 277-285. http://dx. doi. org/10. 1016/j. tim. 2013. 02. 005.
9. Stein RA. 2011. Epigenetics-the link between infectious diseases and cancer. JAMA 305: 1484-1485. http://dx. doi. org/10. 1001/jama. 2011. 446.
10. Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J. 2009. The importance of epigenetic alterations in the development of Epstein-Barr virus-related lymphomas. Mediterr. J. Hematol. Infect Dis. 1: e2009012. http://dx. doi. org/10. 4084/MJHID. 2009. 012.
11. Minárovits J. 2009. Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review. Acta. Microbiol. Immunol. Hung. 56: 1-19. http://dx. doi. org/10. 1556/AMicr. 56. 2009. 1. 1.
12. Poreba E, Broniarczyk JK, Gozdzicka-Jozefiak A. 2011. Epigenetic mechanisms in virus-induced tumorigenesis. Clin. Epigenetics 2: 233-247. http://dx. doi. org/10. 1007/s13148-011-0026-6.
13. Paschos K, Allday MJ. 2010. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 18: 439-447. http://dx. doi. org/10. 1016/j. tim. 2010. 07. 003.
14. Niller HH, Banati F, Nagy K, Buzas K, Minarovits J. 2013. Update on microbe-induced epigenetic changes: bacterial effectors and viral oncoproteins as epigenetic dysregulators. Future Virol. 8: 1111-1126. http://dx. doi. org/10. 2217/fvl. 13. 97.
15. Greenspan D, Greenspan JS. 1997. Oral manifestations of HIV infection. AIDS Clin. Care 9: 29-33.
16. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1: 273-296. http://dx. doi. org/10. 1146/annurev. pathol. 1. 110304. 100133.
17. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ. 2000. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 89: 299-304. http://dx. doi. org/10. 1016/S1079-2104(00)70092-8.
18. Ceballos-Salobreña A, Gaitán-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. 2000. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDs 14: 627-635. http://dx. doi. org/10. 1089/10872910050206540.
19. Patton LL. 2000. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90: 182-188. http://dx. doi. org/10. 1067/moe. 2000. 108799.
20. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 2005. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J. Virol. 79: 7338-7348. http://dx. doi. org/10. 1128/JVI. 79. 12. 7338-7348. 2005.
21. Loesche WJ. 1982. Dental caries: a treatable infection. Charles C. Thomas Publisher, Springfield, IL.
22. Nair BC, Mayberry WR, Dziak R, Chen PB, Levine MJ, Hausmann E. 1983. Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J. Periodontal Res. 18: 40-49. http://dx. doi. org/10. 1111/j. 1600-0765. 1983. tb00333. x.
23. Potempa J, Pike R, Travis J. 1995. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect. Immun. 63: 1176-1182.
24. Grenier D, Mayrand D. 1987. Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect. Immun. 55: 111-117.
25. Takahashi N, Sato T, Yamada T. 2000. Metabolic pathways for cytotoxic end product formation from glutamate-and aspartate-containing peptides by Porphyromonas gingivalis. J. Bacteriol. 182: 4704-4710. http://dx. doi. org/10. 1128/JB. 182. 17. 4704-4710. 2000.
26. Kurita-Ochiai T, Fukushima K, Ochiai K. 1995. Volatile fatty acids, metabolic by-products of periodontopathic bacteria, inhibit lymphocyte proliferation and cytokine production. J. Dent. Res. 74: 1367-1373. http://dx. doi. org/10. 1177/00220345950740070801.
27. TollefsbolTO(ed). 2012. Epigenetics and human infectious diseases, p. In Epigenetics in human disease. Elsevier/AP, Amsterdam, The Netherlands577.
28. Margolis HC, Duckworth JH, Moreno EC. 1988. Composition and buffer capacity of pooled starved plaque fluid from caries-free and cariessusceptible individuals. J. Dent. Res. 67: 1476-1482. http://dx. doi. org/10. 1177/00220345880670120701.
29. Ebe N, Hara-Yokoyama M, Iwasaki K, Iseki S, Okuhara S, Podyma-Inoue KA, Terasawa K, Watanabe A, Akizuki T, Watanabe H, Yanagishita M, Izumi Y. 2011. Pocket epithelium in the pathological setting for HMGB1 release. J. Dent. Res. 90: 235-240. http://dx. doi. org/10. 1177/0022034510385688.
30. Kepler GM, Nguyen HK, Webster-Cyriaque J, Banks HT. 2007. A dynamic model for induced reactivation of latent virus. J. Theor. Biol. 244: 451-462. http://dx. doi. org/10. 1016/j. jtbi. 2006. 08. 020.
31. Morris TL, Arnold RR, Webster-Cyriaque J. 2007. Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus. J. Virol. 81: 6032-6042. http://dx. doi. org/10. 1128/JVI. 02504-06.
32. Nusinzon I, Horvath CM. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. U. S. A. 100: 14742-14747. http://dx. doi. org/10. 1073/pnas. 2433987100.
33. Icardi L, Lievens S, Mori R, Piessevaux J, De Cauwer L, De Bosscher K, Tavernier J. 2012. Opposed regulation of type I IFN-induced. STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J. 26: 240-249. http://dx. doi. org/10. 1096/fj. 11-191122.
34. Löe H, Anerud A, Boysen H. 1992. The natural history of periodontal disease in man: prevalence, severity, and extent of gingival recession. J. Periodontol. 63: 489-495. http://dx. doi. org/10. 1902/jop. 1992. 63. 6. 489.
35. Slots J. 2010. Human viruses in periodontitis. Periodontol. 2000 53: 89-110. http://dx. doi. org/10. 1111/j. 1600-0757. 2009. 00325. x.
36. Contreras A, Slots J. 2000. Herpesviruses in human periodontal disease. J. Periodontal Res. 35: 3-16. http://dx. doi. org/10. 1034/j. 1600-0765. 2000. 035001003. x.
37. Slots J, Ting M. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol. 2000 20: 82-121. http://dx. doi. org/10. 1111/j. 1600-0757. 1999. tb00159. x.
38. Slots J. 2005. Herpesviruses in periodontal diseases. Periodontol. 2000 38: 33-62. http://dx. doi. org/10. 1111/j. 1600-0757. 2005. 00109. x.
39. Kubar A, Saygun I, Ozdemir A, Yapar M, Slots J. 2005. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J. Periodontal Res. 40: 97-104. http://dx. doi. org/10. 1111/j. 1600-0765. 2005. 00770. x.
40. Li H, Chen V, Chen Y, Baumgartner JC, Machida CA. 2009. Herpesviruses in endodontic pathoses: association of Epstein-Barr virus with irreversible pulpitis and apical periodontitis. J. Endod. 35: 23-29. http://dx. doi. org/10. 1016/j. joen. 2008. 09. 017.
41. Sabeti M, Valles Y, Nowzari H, Simon JH, Kermani-Arab V, Slots J. 2003. Cytomegalovirus and Epstein-Barr virus DNA transcription in endodontic symptomatic lesions. Oral Microbiol. Immunol. 18: 104-108. http://dx. doi. org/10. 1034/j. 1399-302X. 2003. 00055. x.
42. Slots J, Kamma JJ, Sugar C. 2003. The herpesvirus-Porphyromonas gingivalis-periodontitis axis. J. Periodontal Res. 38: 318-323. http://dx. doi. org/10. 1034/j. 1600-0765. 2003. 00659. x.
43. Saygun I, Kubar A, Ozdemir A, Yapar M, Slots J. 2004. Herpesviralbacterial interrelationships in aggressive periodontitis. J. Periodontal Res. 39:-207-212. http://dx. doi. org/10. 1111/j. 1600-0765. 2004. 00728. x.
44. Slots J. 2004. Herpesviruses, the missing link between gingivitis and periodontitis? J. Int. Acad. Periodontol. 6: 113-119. http://www. ncbi. nlm. nih. gov/pubmed/15553977.
45. Ferreira DC, Rôças IN, Paiva SS, Carmo FL, Cavalcante FS, Rosado AS, Santos KR, Siqueira JF. 2011. Viral-bacterial associations in acute apical abscesses. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 112: 264-271. http://dx. doi. org/10. 1016/j. tripleo. 2011. 01. 029.
46. Imai K, Inoue H, Tamura M, Cueno ME, Inoue H, Takeichi O, Kusama K, Saito I, Ochiai K. 2012. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie 94: 839-846. http://dx. doi. org/10. 1016/j. biochi. 2011. 12. 001.
47. Imai K, Ogata Y, Ochiai K. 2012. Microbial interaction of periodontopathic bacteria and Epstein-Barr virus and their implication of periodontal diseases. J. Oral Biosci. 54: 164-168. http://dx. doi. org/10. 1016/j. job. 2012. 07. 001.
48. Imai K, Yamada K, Tamura M, Ochiai K, Okamoto T. 2012. Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. Cell. Mol. Life Sci. 69: 2583-2592. http://dx. doi. org/10. 1007/s00018-012-0936-2.
49. Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. 2009. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc. Natl. Acad. Sci. U. S. A. 106: 18786-18791. http://dx. doi. org/10. 1073/pnas. 0905859106.
50. Yin L, Chung WO. 2011. Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol. 4: 409-419. http://dx. doi. org/10. 1038/mi. 2010. 83.
51. Winder DM, Pett MR, Foster N, Shivji MK, Herdman MT, Stanley MA, Venkitaraman AR, Coleman N. 2007. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J. Pathol. 213: 27-34. http://dx. doi. org/10. 1002/path. 2206.
52. Foster SL, Hargreaves DC, Medzhitov R. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978. http://dx. doi. org/10. 1038/nature05836.
53. De Camargo Pereira G, Guimarães GN, Planello AC, Santamaria MP, de Souza AP, Line SR, Marques MR, Guimarães GN. 2013. Porphyromonas gingivalis LPS stimulation downregulates DNMT1, DNMT3a, and JMJD3 gene expression levels in human HaCaT keratinocytes. Clin. Oral Investig. 17: 1279-1285. http://dx. doi. org/10. 1007/s00784-012-0816-z.
54. Sawamoto Y, Sugano N, Tanaka H, Ito K. 2005. Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol. Immunol. 20: 216-220. http://dx. doi. org/10. 1111/j. 1399-302X. 2005. 00215. x.
55. Licciardi PV, Wong SS, Tang ML, Karagiannis TC. 2010. Epigenome targeting by probiotic metabolites. Gut Pathog. 2: 24. http://dx. doi. org/10. 1186/1757-4749-2-24.
56. Tezal M, Grossi SG, Genco RJ. 2005. Is periodontitis associated with oral neoplasms? J. Periodontol. 76: 406-410. http://dx. doi. org/10. 1902/jop. 2005. 76. 3. 406.
57. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA. 2009. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 18: 2406-2412. http://dx. doi. org/10. 1158/1055-9965. EPI-09-0334.
58. Psyrri A, DiMaio D. 2008. Human papillomavirus in cervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 5: 24-31. http://dx. doi. org/10. 1038/ncponc0984.
59. Tezal M, Scannapieco FA, Wactawski-Wende J, Hyland A, Marshall JR, Rigual NR, Stoler DL. 2012. Local inflammation and human papillomavirus status of head and neck cancers. Arch. Otolaryngol. Head Neck Surg. 138: 669-675. http://dx. doi. org/10. 1001/archoto. 2012. 873.
60. Tezal M, Sullivan Nasca M, Stoler DL, Melendy T, Hyland A, Smaldino PJ, Rigual NR, Loree TR. 2009. Chronic periodontitis-human papillomavirus synergy in base of tongue cancers. Arch. Otolaryngol. Head Neck Surg. 135: 391-396. http://dx. doi. org/10. 1001/archoto. 2009. 6.
61. Schwartz J. 2012. Poly-microbial interaction with human papilloma virus leading to increased risk for head and neck squamous cell carcinoma and oral squamous cell carcinomas, p 75-106. In Radosevich JA (ed), HPVand cancer. Springer Verlag, Dordrecht, The Netherlands.
62. Thain A, Jenkins O, Clarke AR, Gaston K. 1996. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 70: 7233-7235.
63. Badal V, Chuang L, Tan E. 2003. CpG methylation of human papillomavirus type 16DNAin cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic. J. Virol. 77: 6227-6234. http://dx. doi. org/10. 1128/JVI. 77. 11. 6227-6234. 2003.
64. Sartor MA, Dolinoy DC, Jones TR, Colacino JA, Prince ME, Carey TE, Rozek LS. 2011. Genome-wide methylation and expression differences in HPV(_) and HPV(_) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 6: 777-787. http://dx. doi. org/10. 4161/epi. 6. 6. 16216.
65. Imai K, Ochiai K, Okamoto T. 2012. Microbial interaction between HIV-1 and anaerobic bacteria producing butyric acid: its potential implication in AIDS progression. Future Virol. 7: 1005-1014. http://dx. doi. org/10. 2217/fvl. 12. 92.
66. Imai K, Victoriano AF, Ochiai K, Okamoto T. 2012. Microbial interaction of periodontopathic bacterium Porphyromonas gingivalis and HIVpossible causal link of periodontal diseases to AIDS progression-. Curr. HIV Res. 10: 238-244. http://dx. doi. org/10. 2174/157016212800618183.
67. Gori A, Tincati C, Rizzardini G, Torti C, Quirino T, Haarman M, Ben Amor K, van Schaik J, Vriesema A, Knol J, Marchetti G, Welling G, Clerici M. 2008. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol. 46: 757-758. http://dx. doi. org/10. 1128/JCM. 01729-07.
68. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
69. Haynes BF. 2006. Gut microbes out of control in HIV infection. Nat. Med. 12: 1351-1352. http://dx. doi. org/10. 1038/nm1206-1351.
70. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. 2005. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 191: 25-32. http://dx. doi. org/10. 1086/426394.
71. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT. 2000. Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J. Infect. Dis. 181: 1574-1580. http://dx. doi. org/10. 1086/315455.
72. Schmid G, Markowitz L, Joesoef R, Koumans E. 2000. Bacterial vaginosis and HIV infection. Sex. Transm. Infect. 76: 3-4. http://dx. doi. org/10. 1136/sti. 76. 1. 3.
73. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. 2008. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493-1501. http://dx. doi. org/10. 1097/QAD. 0b013e3283021a37.
74. Galvin SR, Cohen MS. 2004. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2: 33-42. http://dx. doi. org/10. 1038/nrmicro794.
75. Imai K, Ochiai K, Okamoto T. 2009. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J. Immunol. 182: 3688-3695. http://dx. doi. org/10. 4049/jimmunol. 0802906.
76. Fukayama M, Hino R, Uozaki H. 2008. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci. 99: 1726-1733. http://dx. doi. org/10. 1111/j. 1349-7006. 2008. 00888. x.
77. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345: 784-789. http://dx. doi. org/10. 1056/NEJMoa001999.
78. Lima VP, de Lima MA, André AR, Ferreira MV, Barros MA, Rabenhorst SH. 2008. H. pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J. Gastroenterol. 14: 884-891. http://dx. doi. org/10. 3748/wjg. 14. 884.
79. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP. 1999. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59: 5438-5442.
80. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W. 2003. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci. 94: 901-905. http://dx. doi. org/10. 1111/j. 1349-7006. 2003. tb01373. x.
81. Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. 2008. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol. Rep. 19: 197-202. http://dx. doi. org/10. 3892/or. 19. 1. 197.
82. Katayama Y, Takahashi M, Kuwayama H. 2009. Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem. Biophys. Res. Commun. 388: 496-500. http://dx. doi. org/10. 1016/j. bbrc. 2009. 08. 003.
83. Wijnhoven BP, Dinjens WN, Pignatelli M. 2000. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br. J. Surg. 87: 992-1005. http://dx. doi. org/10. 1046/j. 1365-2168. 2000. 01513. x.
84. Becker K, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. 1994. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54: 3845-3852.
85. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. 2000. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 26: 16-17. http://dx. doi. org/10. 1038/79120.
86. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. 2003. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52: 502-506. http://dx. doi. org/10. 1136/gut. 52. 4. 502.
87. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. 2006. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 55: 463-468. http://dx. doi. org/10. 1136/gut. 2005. 077776.
88. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. 2008. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 13: 35-41. http://dx. doi. org/10. 1111/j. 1523-5378. 2008. 00639. x.
89. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. 2006. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12: 989-995. http://dx. doi. org/10. 1158/1078-0432. CCR-05-2096.
90. Young LS, Murray PG. 2003. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108-5121. http://dx. doi. org/10. 1038/sj. onc. 1206556.
91. Bhende PM, Seaman WT, Delecluse H-J, Kenney SC. 2004. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36: 1099-1104. http://dx. doi. org/10. 1038/ng1424.
92. Li H, Minarovits J. 2003. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 89: 133-156. http://dx. doi. org/10. 1016/S0065-230X(03)01004-2.
93. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC. 2009. Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog. 5: e1000356. http://dx. doi. org/10. 1371/journal. ppat. 1000356.
94. Sakuma K, Chong JM, Sudo M, Ushiku T, Inoue Y, Shibahara J, Uozaki H, Nagai H, Fukayama M. 2004. High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int. J. Cancer 112: 273-278. http://dx. doi. org/10. 1002/ijc. 20420.
95. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY. 2002. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol. 160: 787-794. http://dx. doi. org/10. 1016/S0002-9440(10)64901-2.
96. Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T. 2006. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 106: 1467-1479. http://dx. doi. org/10. 1002/cncr. 21789.
97. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. 2004. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164: 689-699. http://dx. doi. org/10. 1016/S0002-9440(10)63156-2.